Are you a healthcare professional?
This content is intended exclusively for healthcare professionals.
The content is for informational purposes only and is not intended for the general public.
Enhancing biological knowledge through proteomics
Measures the concentration of thousands of human proteins using minimal sample quantities.
Proteomics takes the success of genomics further, offering dynamic, real-time insights into human biology and its changes—key for advancing precision medicine.
Discover how Olink Reveal can help you unlock new possibilities in proteomics and achieve your goals with ease.
More Data. Less effort.
Thanks to its proprietary Proximity Extension Assay (PEA) technology, Olink® Explore enables accurate and simultaneous quantification of hundreds to thousands of protein biomarkers secreted in human body fluids. The Olink platform offers the accuracy and sensitivity of manual techniques with minimal sample requirements.
The incorporation of NGS allows greater scalability of samples and biomarkers analyzed simultaneously without affecting data quality and reducing costs.
Olink Explore
Olink Explore technology consists of eight Explore 384-plex panels focused on diseases and biological processes. This flexible and scalable offer uses approximately 1 µL of blood sample per 384-plex panel.
You can test all panels simultaneously (Explore 3072) or focus on one or more of the Explore 384-plex panels.
Olink® Explore 384 Cardiometabolic I and II
Olink® Explore 384 Inflammation I and II
Olink® Explore 384 Neurology I and II
Olink® Explore 384 Oncology I and II
Endless possibilities on a single platform
Olink Explore is a high-value platform for studies involved in drug development, clinical research or basic research aiming to perform large-scale discovery proteomics studies.
What makes Olink® Explore different?
The study of the secretome has been limited by the lack of tools to accurately and precisely analyze its complexity. Olink Explore provides an answer to all these limitations:
High sensibility
Outstanding specificity
>3.000 biomarkers
Minimal sample requirements (<1 μl para 384-plex, <6 μl para 3072-plex)
Broad dynamic range (femtograms to milligrams)
Olink® Reveal
Accessible NGS-based
proteomics for every lab.
Analyze more than 1,000 proteins using just 4 µL of sample.
Our protein selection focuses on circulating, druggable, and robustly detectable proteins, with a particular emphasis on those involved in inflammation and immune response.
Empowered for inflammatory studies
96%
Of all immune response pathways covered
Genetically validated
>700
Proteins with documented cis-pQTLs
Broad proteome coverage
100% top level pathways and 64% of all pathways in Reactome
Deep profiling of inflammation
537 inflammation proteins covering 96% of immune response pathways in Reactome
Curated library
> 1000 proteins, robustly detectable markers, with high proportion of cis-pQTLs for proteogenomics associations
Innovación para el descubrimiento de biomarcadores proteicos y el análisis de proteínas
Unprecedented power
Olink Explore has emerged as an essential technology in personalized medicine for the identification and monitoring of biomarkers for early diagnosis, prognosis, improved patient stratification, and follow-up of treatment response (>1,400 publications).
Supporting the complete drug development process
Research
Discovery of a therapeutic target
Preclinical research
In vivo/in vitro testing
Clinical development
Phase 1
Dosage and safety
Phase 2
Efficacy/side effects
Phase 3
Effect/adverse event
Phase 4
Post-market surveillance
Our workflow
First session
Analysis service contract and dispatch of the sample form
Samples delivery
Sample processing
Results analysis
Report submission
Do you have any questions?
Request a budget here!